Company Filing History:
Years Active: 2006
Title: Andréa Pavirani: Innovator in Adenoviral Therapeutics
Introduction
Andréa Pavirani is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of biotechnology, particularly in the development of adenoviral therapies. With a total of 2 patents, his work focuses on innovative methods for gene transfer and expression.
Latest Patents
Pavirani's latest patents include groundbreaking inventions related to defective adenoviruses. These patents detail novel defective adenoviruses designed for the transfer and expression of exogenous nucleotide sequences in host cells or organisms. The inventions also encompass novel complementation lines and outline the processes for preparing these adenoviruses. Furthermore, they discuss their therapeutic applications and the pharmaceutical compositions that incorporate them.
Career Highlights
Andréa Pavirani is currently associated with Transgene S.A., a company dedicated to developing innovative immunotherapies for cancer and infectious diseases. His expertise in adenoviral technology has positioned him as a key figure in advancing therapeutic strategies in this domain.
Collaborations
Throughout his career, Pavirani has collaborated with esteemed colleagues such as Jean-Luc Imler and Majid Mehtali. These partnerships have fostered a collaborative environment that enhances research and development efforts in the field of biotechnology.
Conclusion
Andréa Pavirani's contributions to the field of adenoviral therapeutics exemplify his commitment to innovation and research. His patents and collaborations continue to influence advancements in gene therapy and biotechnology.